13
Publications
168
Stories per week
15
Expert Writers
950,000
Subscribers

Everybody follows what’s happening. Our editors know what it means.

Learn More

More than 1,000,000 industry decision-makers and influencers turn here all year to keep up with the Life Sciences market and ahead of the competition.

Learn More

Explore Our Life Sciences Publications
Biotech FierceBiotechIT

Target Audience

Professional Audience
A global community of drug development professionals, market analysts and investors, focused on the C-suite, but broadly relevant to everyone who has a professional role or interest in drug development, primarily in the U.S., with a growing emphasis on Europe and Asia. 

Content Focus
Full spectrum clinical stage drug development, deals and data on the most compelling therapies in the pipeline, the ongoing restructuring of the industry’s R&D efforts, with a sharp focus on leadership.

30
Stories per week
2
Expert Writers
155000
Subscribers
Daily
Frequency

Latest Stories

Pharma FiercePharma

Target Audience

Professional Audience
Wide range of drug company executives from the C-suite to sales reps and manufacturing managers. Readership also includes contractors and others with a professional interest in the pharma industry. U.S. represents the largest audience segment followed by U.K. and Indian markets. Readership in other European and Asian markets is growing rapidly, particularly in countries with big concentrations of pharma companies, such as Germany, Denmark, France, China and Japan.

Content Focus
Broad coverage serving a wide range of specific functional interests including: manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline and the influence of big data, executive moves and social media on it all.

30
Stories per week
3
Expert Writers
160000
Subscribers
Daily
Frequency

Latest Stories

Medical Devices FierceMedicalDevices

Target Audience

Professional Audience
Medical device executives and entrepreneurs are the core audience, with additional readership from service sectors such as its investors, lawyers and accountants.

Content Focus 
Emerging technologies such as wireless connectivity, advanced materials, nanotechnology and biological materials, and the regulatory, market, legal and financial issues and dynamics driving the sector.

30
Stories per week
3
Expert Writers
90000
Subscribers
Daily
Frequency

Latest Stories

Biotech Research FierceBiotech Research

Target Audience

Professional Audience
A mix of industry and academic researchers who lead much of this work along with the large contingent of biotech executives and venture players looking to invest in next-gen therapies. 

Content Focus
New companies, therapies and technologies, government funding for preclinical research, NIH grants, early-stage biotech work, animal studies and alternative funding mechanisms for drug research.

6
Stories per week
1
Expert Writer
50000
Subscribers
Weekly
Frequency

Latest Stories

Pharma Manufacturing PharmaManufacturing

Target Audience

Professional Audience
C-level executives overseeing manufacturing and quality control concerns, mid-level management tied to plants and supply chain responsibilities, drug wholesalers, healthcare executives concerned with drug shortages, investors and consultants.  
 
Content Focus
Technology, science, efficiency, regulation, leadership and their impact on competition.

12
Stories per week
1
Expert Writer
40000
Subscribers
Semi-Weekly
Frequency

Latest Stories

Diagnostics FierceDiagnostics

Target Audience

Professional Audience
Wide scope of biotech and pharma industry executives, as well as the C-level suite, entrepreneurs and service providers within the diagnostics sector itself.

Content Focus
Scientific developments — particularly in response to the growing understanding of genomics and biomarkers — plus deal-making and regulatory actions that challenge and define the industry and the role the it plays in relation to biopharma.

6
Stories per week
1
Expert Writer
30000
Subscribers
Weekly
Frequency

Latest Stories

Biotech IT FierceBiotechIT

Target Audience

Professional Audience
C-level executives at biopharma technology companies.

Content Focus
New technologies for conducting, monitoring and analyzing clinical trials; trends in how companies manage patient data; methods researchers use for storing and using genomic information; the changing regulatory environment.

6
Stories per week
1
Expert Writer
25000
Subscribers
Weekly
Frequency

Latest Stories

Pharma Marketing FiercePharmaMarketing

Target Audience

Professional Audience
Drug company marketing teams and brand managers, sales managers and sales reps, C-suite, plus advertising and media agencies, sales and marketing consultants, and others with a professional interest in pharma marketing. The U.S. represents the largest readership segment, followed by Asia and Europe.

Content Focus
Competition and rivalries as new therapies near market, availability and market impact of new research data, DTC campaigns and disease-awareness efforts, sales and marketing strategies for reaching physicians and relieving pressure from payers, the “empowered patient” affect, how technology and innovation such as big data, social media, new sensor/tracking technologies, and narrowly targeted marketing and advertising mechanisms are changing the game.

12
Stories per week
3
Expert Writers
30000
Subscribers
Semi-Weekly
Frequency

Latest Stories

Drug Delivery FierceDrugDelivery

Target Audience

Professional Audience
Wide scope of biotech and pharma industry executives, as well as those from contract research organizations who need to know first about developments in drug delivery.

Content Focus
Innovative drug delivery technology such as gene therapy, RNAi, novel devices and the partnering and acquisition activity that influences their investment, development, adaptation and use.

6
Stories per week
2
Expert Writers
20000
Subscribers
Weekly
Frequency

Latest Stories

CRO FierceCRO

Target Audience

Professional Audience
Employees at contract R&D organizations. FierceCRO focuses on C-suite execs, and attracts a wide readership of middle managers and members of research teams. 

Content Focus
Deals and partnerships between CROs and drugmakers, financial results, new analytical technologies, changing regulations, consolidation and M&A, contract manufacturers, preclinical service providers and academic institutions that carry out contract work.

6
Stories per week
1
Expert Writer
25000
Subscribers
Weekly
Frequency

Latest Stories

Vaccines FierceVaccines

Target Audience

Professional Audience 
High-level execs in the vaccine industry, either in development, industry or sales, who are closely tracking R&D and market developments. 

Content Focus
Discovery and development, venture capital and finance, clinical trials, regulatory affairs, manufacturing, licensing and M&A, and sales and marketing across a broad range of patient needs and market conditions.

6
Stories per week
2
Expert Writers
30000
Subscribers
Weekly
Frequency

Latest Stories

Pharma Asia FiercePharmaAsia

Target Audience

Professional Audience:
Senior business executives and clinical operations leaders at biotech, pharmaceutical, and related drug development companies.  


Content Focus: 
Asia’s Biopharma News Monitor, FiercePharmaAsia covers the Asia Pacific market – including pharma market news, drug development, new deals, collaborations, advances and setbacks on clinical trials, biopharma regulatory challenges and approvals and rejections of new drug applications.

12
Stories per week
1
Expert Writer
6500
Subscribers

Latest Stories

Animal Health FierceAnimalHealth

Target Audience

Professional Audience
Top executives from both private and publicly held animal health companies, as well as salespeople, investors, and researchers working in animal health.

Content Focus
Drug development for pets and farm animals, diagnostics, nutritional products, practice-management technologies, and other health-related products for the veterinary market, pet insurance, animal health regulation, and basic science developments coming out of veterinary schools worldwide.

 

10000
Subscribers
2
Expert Writers
Weekly
Frequency
6
Stories per week

Latest Stories

Life Sciences Editorial Staff
John Carroll
John Carroll Editor-In-Chief

John Carroll

Editor-In-Chief

John D. Carroll is a biotech analyst with 35 years of prize-winning experience in journalism. Aside from his daily industry coverage for FierceBiotech, where he was named editor in 2003, Carroll has been a regular speaker at biotech events around the globe. He's been a keynote speaker for several state associations as well as biotech groups in London and Cambridge, U.K.; addressed student audiences at MIT and Harvard; and been quoted in The New Yorker, the Financial Times, the Boston Globe and other publications. Carroll has covered genomics, biotechnology, healthcare and other business topics for American Banker, Managed Care and many other publications. He has contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press. Carroll spent 6 years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times. 

Latest by John Carroll

Tracy Staton
Tracy Staton Senior Editor

Tracy Staton

Senior Editor

Tracy Staton is the editor of FiercePharma and FiercePharmaMarketing. She has been a freelance writer for 8 years. Before that, she served as editor of the Dallas Business Journal, editor of Texas Business magazine, and a senior editor at American Way, the inflight magazine of American Airlines. She is based in Vermont.

Latest by Tracy Staton

Eric Palmer
Eric Palmer Senior Editor

Eric Palmer

Senior Editor

Eric Palmer is a business and technology journalist with more than three decades of prize-winning experience as a reporter and editor with daily, weekly, monthly and online publications. He was healthcare reporter for The Kansas City Star before becoming deputy business editor for the daily newspaper. He spent 8 years as editor of The Kansas City Business Journal, which had a strong emphasis on the healthcare industry. He is an avid fly fisherman, cooks and collects wine, and likes to travel with his family. 

Latest by Eric Palmer

Stacy Lawrence
Stacy Lawrence Senior Editor

Stacy Lawrence

Senior Editor

Stacy has been writing and editing about the business of emerging technologies for more than 15 years. Most recently, she was the biopharma business bureau editor with Elsevier. Prior to that, she was the finance columnist with biotechnology industry publication BioCentury. Stacy also has written for publications including Nature Biotechnology, San Francisco Business Times, New Scientist, MIT Technology Review, Business 2.0, and Wired. 

Latest by Stacy Lawrence

Damian Garde
Damian Garde Senior Editor

Damian Garde

Senior Editor

Damian is an editor with FierceMarkets' Life Sciences publications, writing for FierceBiotech, FierceMedicalDevices and FierceCRO. Prior to joining Fierce, he worked for Patch.com in Maryland, and The Albuquerque Journal and Weekly Alibi in Albuquerque, NM. Damian lives in Washington, DC, and considers himself the foremost Carmelo Anthony apologist in the greater metropolitan area. 

Latest by Damian Garde

Michael Gibney
Michael Gibney Production Editor

Michael Gibney

Production Editor

Michael is the production editor with FierceMarkets' Life Sciences group. He also writes for FierceDrugDelivery and FierceMedicalDevices. A graduate of the University of Missouri's School of Journalism, Michael has worked as an editor for Patch.com in Connecticut and a writer for the Bozeman Daily Chronicle in Montana. Michael lives in Washington, DC, and enjoys hiking, running and exploring the city's bookstores and movie theaters. 

Latest by Michael Gibney

Carly Helfand
Carly Helfand Editor

Carly Helfand

Editor

Carly Helfand is a news editor with FierceMarkets' Life Sciences group, writing for FierceVaccines, FiercePharma and FiercePharmaMarketing. Carly got her start covering pharma while earning her master's at Northwestern University's Medill School of Journalism, where she concentrated in business reporting. She has completed journalism projects on four continents, and her work has appeared in various outlets such as The Boston Globe, The Washington Post's Wonkblog and Cape Town's Weekend Argus. Carly prefers watching pro hockey to nearly everything. She also plays the Irish fiddle. 

Latest by Carly Helfand

Varun Saxena
Varun Saxena Editor

Varun Saxena

Editor

Varun Saxena is a news editor with the FierceMarkets Life Sciences group. He edits and writes for FierceMedicalDevices and FierceDrugDelivery. Prior to joining Fierce he covered the medical device and diagnostics industry for The Gray Sheet. He has had stints at The Indianapolis Star, the Chronicle of Higher Education and Kiplinger's Personal Finance magazine. Varun is a graduate of George Washington University, from which he earned a Bachelor's in Economics. In addition, he has a Master's in Journalism from the University of Maryland. He is a member of the National Press Club and the South Asian Journalists Association. 

Latest by Varun Saxena

Emily Wasserman
Emily Wasserman Editor

Emily Wasserman

Editor

Emily Wasserman is a news editor for FierceMarkets' Life Sciences group. Prior to joining Fierce, Emily completed her Master's at Northwestern University's Medill School of Journalism. She specialized in magazine journalism, and also worked as a Health and Science reporter for the school's wire news service. She covered topics ranging from America's obesity epidemic to genetically modified fish, and her work appeared in local and national publications. In her spare time, Emily freelances for Fodor's Travel and maintains a personal food blog.

Latest by Emily Wasserman

Amirah Al Idrus
Amirah Al Idrus Associate Editor

Amirah Al Idrus

Associate Editor

Amirah Al Idrus is a copy editor for the FierceMarkets Life Sciences group and a contributing writer for FierceVaccines. Before joining the Fierce Life Sciences team, Amirah completed a master's degree in journalism at the University of Maryland, where she concentrated in online and multimedia journalism. While at Maryland, she worked for the university's Capital News Service as a web designer and developer, and interned at the Washington Business Journal. She has covered issues ranging from Maryland politics and local business to finance in state prisons. When she's not working, Amirah spends her time running around D.C. and Silver Spring, visiting museums, and baking (and eating) pies. 

Latest by Amirah Al Idrus

Eric Sagonowsky
Eric Sagonowsky Associate Editor

Eric Sagonowsky

Associate Editor

Eric Sagonowsky is an associate editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University’s E.W. Scripps School of Journalism in 2012 with a degree in Online Journalism. On campus, Eric wrote for The Athens News and The New Political. In his free time, Eric enjoys outdoor recreation, following sports of all kinds and exploring the metro D.C. area. 

Latest by Eric Sagonowsky

You're mobile. So are we.

FierceBiotech

Includes the following publications:

  • FierceBiotechIT
  • FiercePharma

    Includes the following publications:

  • FiercePharma